EBCC 2024 | MAMA_MOVE Gaia After Treatment: introducing exercise in cancer survivors

Ana Joaquim, MD, PhD, European Organisation for Research and Treatment of Cancer, Brussels, Belgium, discusses findings from the MAMA_MOVE Gaia After Treatment trial (NCT04024280), which assessed the benefits of exercise in survivors of breast cancer. Participants initially were in a 16-week control phase followed by a 16-week intervention phase consisting of aerobic and resistance training. The primary endpoint of global health status did not decline in participants, and other secondary endpoints such as health-related quality of life and cardiometabolic biomarkers are currently undergoing analysis. This interview took place at the 14th European Breast Cancer Conference (EBCC) in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.